Effect of the change in antiviral therapy indication on identifying significant liver injury among chronic hepatitis B virus infections in the grey zone.

导出 LinkOut

翻译打印收藏纠错

作者： Shan,Ren ^[1] ; Wenjing,Wang ^[2] ; Junfeng,Lu ^[1] ; Kefei,Wang ^[1] ; Lina,Ma ^[1] ; Yanhong,Zheng ^[1] ; Sujun,Zheng ^[1] ; Xinyue,Chen ^[1]

作者单位： First Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, Beijing, China. ^[1] Beijing Institute of Hepatology Beijing Youan Hospital, Capital Medical University, Beijing, China. ^[2]

关键词 alanine aminotransferase (ALT)antiviral therapy chronic hepatitis B (CHB)grey zone (GZ)indication liver biopsy significant liver injury

主题词男(雄)性(Male);人类(Humans);女(雌)性(Female);成年人(Adult);乙型肝炎, 慢性(Hepatitis B, Chronic);乙型肝炎e抗原(Hepatitis B e Antigens);DNA, 病毒(DNA, Viral);乙型肝炎病毒(Hepatitis B virus);回顾性研究(Retrospective Studies);白细胞介素6(Interleukin-6);乙型肝炎表面抗原(Hepatitis B Surface Antigens);肝硬化(Liver Cirrhosis);抗病毒药(Antiviral Agents);炎症(Inflammation)

DOI 10.3389/fimmu.2022.1035923

PMID 36389814

发布时间 2022-11-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in immunology

2022年13卷

1035923页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Effect of the change in antiviral therapy indication on identifying significant liver injury among chronic hepatitis B virus infections in the grey zone.

Frontiers in immunology

相似文献

Frontiers in immunology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Effect of the change in antiviral therapy indication on identifying significant liver injury among chronic hepatitis B virus infections in the grey zone.

Frontiers in immunology

相似文献

Frontiers in immunology

相关期刊

检索历史清除